학술논문
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)
Document Type
Article
Author
Source
In Annals of Allergy, Asthma & Immunology November 2022 129(5):592-604
Subject
Language
ISSN
1081-1206